Clinical trial / 2017
Fresh yellow onion intake lowered fasting glucose and insulin resistance during breast cancer chemotherapy.
Eligible breast cancer patients receiving doxorubicin-based chemotherapy were randomized to an 8-week intervention with high daily onion intake (100 to 160 g/d) or low daily onion intake (30 to 40 g/d). Analyses of 23 participants per group revealed that high onion intake significantly decreased fasting blood glucose and insulin levels relative to low onion intake (P < .001). Post-treatment insulin resistance assessed by HOMA-IR was also significantly lower in the high onion group (P < .05).
- Study type
- Randomized controlled trial
- Who was studied
- 56 breast cancer patients receiving chemotherapy
- What was measured
- Fasting blood glucose, insulin levels, and insulin resistance indices
THE PAPER
Consumption of Fresh Yellow Onion Ameliorates Hyperglycemia and Insulin Resistance in Breast Cancer Patients During Doxorubicin-Based Chemotherapy: A Randomized Controlled Clinical Trial.
Jafarpour-Sadegh F, Montazeri V, Adili A, Esfehani A, Rashidi MR, Pirouzpanah S. Integr Cancer Ther, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.